Not checked for notices yet.
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du, Chan Liu, Mengyao Qin and 5 more
Acta Pharmaceutica Sinica B · 2022
doi:10.1016/j.apsb.2021.09.019
Cited by papers we hold 4
- Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation · 2024No notice
- The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer · 2024No notice
- Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside · 2024No notice
- Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma · 2023No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.